Top Papers

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozol... 2014 2026 2018 2022 1.4k
  1. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study (2014)

Citation Paths

Find how Marcus Schmidt's papers are connected to another author through citations.

Rankless by CCL
2026